Zhixuan Li

Zhixuan Li

Auto-generated profile, based on publicly available information

Zhixuan Li

Translational Medicine Research Center, Medical Innovation Research Division and Fourth Medical Center of the Chinese PLA General Hospital, Beijing, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Theranostics
Verified
Journal Article
Open access
YZYan-Jing Zhu
Yan-Jing Zhu
BZBo Zheng
Bo Zheng
GLGui-Juan Luo
Gui-Juan Luo
XMXu-Kai Ma
Xu-Kai Ma
XLXin-Yuan Lu
Xin-Yuan Lu
LCLei Chen
Lei Chen
Circular RNA (circRNA) possesses great pre-clinical diagnostic and therapeutic potentials in multiple cancers. It has been reported playing roles in multiple malignant behaviors including proliferation, migration, metastasis and chemoresistance. However, the underlying correlation between circRNAs and cancer stem cells (CSCs) has not been reported yet.

18 May 2020 in Advanced Science
Verified
Journal Article
Open access
PDF file
BZBo Zheng
Bo Zheng
DWDongfang Wang
Dongfang Wang
XQXinyao Qiu
Xinyao Qiu
GLGuijuan Luo
Guijuan Luo
TWTong Wu
Tong Wu
LCLei Chen
Lei Chen
The spatial heterogeneity of immune microenvironment in hepatocellular carcinoma (HCC) remains elusive. Here, a single‐cell study involving 17 432 600 immune cells of 39 matched HCC (T), nontumor (N), and leading‐edge (L) specimens by mass cytometry is conducted. The tumor‐associated CD4/CD8 double‐positive T (DPT) cells are found enriched in L regions with synergetic expression of PD‐1/HLA‐DR/ICOS/CD45RO and exhibit a higher level of IFN‐γ, TNF‐α, and PD‐1 upon stimulation. The enrichment of DPT and PD‐1+DPT in L regions indicates favorable prognosis. These tumor‐associated DPT cells with similar phenotype are also verified in other tumors and HCC animal models. Single‐cell RNA‐seq further characterizes the molecular features of DPT cells and uncovers 11 clusters with different cytotoxicity, exhaustion, and activation scores. TCR‐based trajectory analysis reveals that tumor‐associated DPT clusters share separated ancestries with local CD4+ or CD8+SPT cells rather than CD3+PBMC cells. TCR clones with frequency above 10 are mainly found coexisting in DPT and CD8+SPT cells. Specifically, PD‐1highDPT cluster (TDPT_10) shares the same ancestry with exhausted CD8+SPT cluster (TCD8T_2) and shows higher expression similarity and closer pathological location to PD‐1+CD8+ than PD‐1+CD4+T cells. Together, this study systematically characterizes the unique distribution of PD‐1+DPTs in HCC and puts forward new insights for the function and origin of tumor‐associated DPT cells.

1 August 2019 in Cancer Letters
Verified
Journal Article
Closed access
ZLZhixuan Li
Zhixuan Li
TWTong Wu
Tong Wu
BZBo Zheng
Bo Zheng
LCLei Chen
Lei Chen

17 August 2024 in Cancer Letters
Verified
Journal Article
Closed access
LZLeqi Zhou
Leqi Zhou
RWRongbo Wen
Rongbo Wen
CBChen Guang Bai
Chen Guang Bai
ZLZhixuan Li
Zhixuan Li
KZKuo Zheng
Kuo Zheng
WZWei Zhang
Wei Zhang

31 March 2023
Verified
Other
Open access
XQXinyao Qiu
Xinyao Qiu
SYShuai Yang
Shuai Yang
SWShan Wang
Shan Wang
JWJianmin Wu
Jianmin Wu
BZBo Zheng
Bo Zheng
LCLei Chen
Lei Chen
Supplementary Table S1. Clinical characteristics of 84 ICC patients depending on ALKBH5 expression levels. Supplementary Table S2. Clinical characteristics of 6 ICC specimens receiving immunotherapy. Supplementary Table S3: m6A-seq identified m6A peaks on PD-L1 mRNA. m6A peaks on PD-L1 mRNA and its corresponding primers for quantitative RT-PCR. Supplementary Table S4. m6A peaks in PD-L1 mRNA in m6A-Seq data from GSE87515.

31 March 2023
Verified
Other
Open access
XQXinyao Qiu
Xinyao Qiu
SYShuai Yang
Shuai Yang
SWShan Wang
Shan Wang
JWJianmin Wu
Jianmin Wu
BZBo Zheng
Bo Zheng
LCLei Chen
Lei Chen
Supplementary Fig. S1. PD-L1 was regulated by ALKBH5 independent on FTO, METTL3 or METTL14. Supplementary Fig. S2. m6A-seq and mRNA-seq of RBE-shCtrl/shALKBH5 cells. Supplementary Fig. S3. Transient ALKBH5 and its mutant H204A overexpression increased the endogenous ALKBH5 protein level. Supplementary Fig. S4. ALKBH5 deficiency accelerates the degradation of PD-L1 mRNA dependent on YTHDF2. Supplementary Fig. S5. The role of YTHDF2 in regulating PD-L1 expression. Supplementary Fig. S6. Tumor cell intrinsic ALKBH5 facilitates tumor resistance to anti-tumor T cell immunity. Supplementary Fig. S7. T cell expansion was inhibited by tumor-intrinsic ALKBH5. Supplementary Fig. S8. The role of ALKBH5 in the proliferation and migration of ICC cell in vitro. Supplementary Fig. S9. PD-L1 is essential for ALKBH5-regulated anti-tumor T cell immunity. Supplementary Fig. S10. The correlation between ALKBH5 and PD-L1 transcripts in TCGA datasets. Supplementary Fig. S11. ALKBH5 positively correlates with PD-L1 expression in clinical ICC specimens. Supplementary Fig. S12. The role of ALKBH5 in ICC immune microenvironment. Supplementary Fig. S13. ALKBH5 deficiency in ICC cells relates to immunosuppressive microenvironment.